Milestones in understanding allergy and its diagnosis

Clinical and Experimental Allergy Reviews

Volumn 2, Issue 1, 2002, Pages 2-7

  Johansson, S G O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergy; Cytokines; Histamine; History; IgE; Mechanisms; Mediators; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CORTISONE; CROMOGLYCATE DISODIUM; HISTAMINE; HISTAMINE RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; STRAMONIUM; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; ANAPHYLAXIS; ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; GROWTH RETARDATION; HAY FEVER; HUMAN; IMMUNOCHEMISTRY; IMMUNOTHERAPY; IN VITRO STUDY; MAST CELL; NONHUMAN; POLLEN; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; TH2 CELL; WORLD HEALTH ORGANIZATION;

EID: 0036425169     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2002.00027.x     Document Type: Article

References (48)

1. Aberg N, Hesselmar B, Aberg B, Eriksson B. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 1995; 25:815-9.
2. Jones NS, Carney AS, Davis A. The prevalence of allergic rhinosinusitis: A review. J Laryngol Otol 1998; 112:1019-30.
3. Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999; 82:23348.
4. Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: Two surveys 15 years apart. Arch Dis Child 1989; 64:1452-6.
5. Kaur B, Butland B. Trends in asthma mortality. Asthma mortality is falling in most age groups in Scotland. BMJ 1997; 315:1014.
6. Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: An international questionnaire study. J Am Acad Dermatol 1996; 34:760-4.
7. Cohen SG. The pharaoh and the wasp. Allergy Proc 1989; 10:149-51.
8. Blackley CHB. Hay fever: Its causes, treatment, and effective prevention, experimental researches. London: Baillière, Tindall & Cox, 1880.
9. von Pirquet C. Allergie. Munch Med Wochenschr 1906; 53:1457.
10. Erhlich P. Uber die specifischen granulationen des Blutes. Arch Anat Physiol Lpz 1879; 3 Physiol Abt:571-9.
11. Dale HH, Laidlaw PP. The physiologic action of betaimidazolyl-ethylamine. J Physiol 1911; 41:318-44.
12. Herxheimer H. Antihistamines in bronchial asthma. BMJ 1949; 2:901-5.
13. Riley J, West GB. Histamine and tissue mast cells. J Physiol 1953; 120:528-37.
14. Ash ASF, Schild HO. Receptors mediating some actions of histamine. Br J Pharmacol 1966; 27:427.
15. Feldberg W, Kellaway CH. Liberation of histamine and formation of lysocithin-like substances by cobra venom. J Physiol 1938; 94:187-91.
16. Samuelsson B. Leukotrienes. mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220:568-75.
17. Ramirez MA. Horse asthma following blood transfusion. Report of a case. JAMA 1919; 73:984.
18. Prausnitz C, Küstner H. Studien über die überemfindlichkeit. Zentralbl Bakteriol I. Abt Orig 1921; 86:160.
19. Ishizaka K, Ishizaka T. Identification of gamma E-antibodies as a carrier of reaginic activity. J Immunol 1967; 99:1187.
20. Bennich H, Johansson SGO. Studies on a new class of human immunoglobulins. II. Chemical and physical properties. In: Killander J, ed. Gammaglobulins. Structure and Control of Biosynthesis. Stockholm: Almqvist & Wiksell, 1967:199-205.
21. Johansson SGO, Bennich H. Studies on a new class of human immunoglobulins. I. Immunological properties. In: Killander J, ed. Gammaglobulins. Structure and Control of Biosynthesis. Stockholm: Almqvist & Wiksell, 1967:193-7.
22. Bennich HH, Ishizaka K, Johansson SGO, Rowe DS, Stanworth DR, Terry WD. Immunoglobulin E, a new class of human immunoglobulin. Bull World Hlth Org 1968; 38:151-2.
23. Johansson SGO, Hourihane JO'B, Bousquet Jet al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 5 6:813-24.
24. Wide L, Bennich H, Johansson S. Diagnosis of allergy by an in vitro test for allergen antibodies. Lancet 1967; 2:1105.
25. Gollasch DR. Zur kenntniss der asthmatischen sputums. Fortschritte Med (Berlin) 1889; 7:361-5.
26. Canon P. Uber eosinophile Zellen und Mastzellen im Blute Gesunder und Kranker. Dtsch Med Wochenschr 1892; 10:206.
27. Neusser E. Klinisch-haematologische mittheilungen. Wien Klin Wochenschr 1892; 5:41-6:64-8.
28. Sabesin SM. A function of the eosinophil. Phagocytosis of antigen-antibody complexes. Proc Soc Exp Biol Medical 1963; 112:667.
29. Goetzl EJ, Wasserman SI, Austen KF. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. Arch Pathol Laboratory Med 1975; 99:1-4.
30. Hytonen M, Sala E. Nasal provocation test in the diagnostics of occupational allergic rhinitis. Rhinology 1996; 34:86-90.
31. Salzano FA. Specific nasal provocation test with powder allergen. Allergy 1997; 52:32-5.
32. Weisnagel J. Antihistamines. An overview of past, present and future. Modern Medicine of Canada. January 1990. http://www.allerg.qc.ca.antihist.htm
33. Altounyan REC, Howell JBL. Treatment of asthma with disodium cromoglycate (FPL 670, 'Intal'). Respiration 1969; 26 (Suppl.): 131-40.
34. Hench PS, Kendall EC, Slocumb CH, Polley HF. The effects of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Proc Staff Meet Mayo Clin 1949; 24:181-97.
35. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1:1572-3.
36. Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911; 2:814-7.
37. Varney VA, Gaga M, Frew AJ et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991; 302:265-9.
38. VanMetre TE Jr, March DG, Adkinson NF Jr et al. Immunotherapy for cat asthma. J Allergy Clin Immunol 1988; 82:1055-68.
39. Bousquet J, Hejjaoui A, Soussana Met al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990; 85:490-7.
40. Horst M, Hejjaoui A, Horst Vet al. Double-blind, placebo-controlled rush immunotherapy with standardized Alternaria extract. J Allergy Clin Immunol 1990; 85:460-72.
41. Hunt KJ, Valentine MD, Sobotka A et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299:157-61.
42. Lichtenstein LM, Norman PS, Winkenwerder WC et al. In vitro studies of human ragweed allergy changes in cellular and humoral activity associated with specific desensitization. J Clin Invest 1966; 45:1126-36.
43. Rocklin RE, Sheffer AL, Greineder DK et al. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Medical 1980; 302:1213-9.
44. Iliopoulos O, Proud D, Adkinson F et al. Effects of immunotherapy on the early, late and rechallenge nasal reaction to provocation with allergen: Changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991; 87:855-66.
45. Furin MJ, Norman PS, Creticos PS et al. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991; 88:27-32.
46. Rak S, Hakanson L, Venge P. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol 1990; 86:706-13.
47. Businco L, Marziali M, Furcolo G, Meglio P. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: First results of ETAC. Early Treatment of the Atopic Child. Pediatr Allergy Immunol 1998; 9:11 6-24.
48. Johansson SGO, Haahtela T, eds. Prevention of Allergy and Asthma Interim Report. Based on the WHO/IAACI Meeting on the Primary Prevention of Allergy and Asthma, Geneva, Switzerland, December 5-6, 1999. Allergy 2000; 55:1069-88.